1. LINE

      Text:AAAPrint
      Sci-tech

      U.S. researchers start testing mix-and-match COVID-19 vaccine boosters

      1
      2021-06-03 09:00:05Xinhua Editor : Li Yan ECNS App Download
      A health care worker prepares a dose of COVID-19 vaccine at a new vaccination site in the California Polytechnic State University in Pomona, Los Angeles County, California, the United States, Feb. 5, 2021. (Xinhua)

      A health care worker prepares a dose of COVID-19 vaccine at a new vaccination site in the California Polytechnic State University in Pomona, Los Angeles County, California, the United States, Feb. 5, 2021. (Xinhua)

      Special: Battle Against Novel Coronavirus

      U.S. researchers have started a clinical trial to test what happens when adults who have been fully vaccinated with one type of COVID-19 vaccine receive booster doses of a different COVID-19 vaccine.

      The trial aims to determine the safety and immunogenicity of mixed boosted regimens, according to the U.S. National Institutes of Health (NIH).

      The trial will include about 150 adults who have been fully vaccinated with one of the three approved COVID-19 vaccines in the United States, the Johnson &Johnson, Moderna or Pfizer vaccines.

      Each vaccine group will enroll about 25 people aged 18 to 55 years, and about 25 people aged 56 years and older. Twelve to 20 weeks following their initial vaccination regimen, participants will receive a single booster dose of the Moderna COVID-19 vaccine as part of the trial.

      People who have not received COVID-19 vaccine are also eligible to enroll in the trial in a separate cohort. These volunteers will initially receive the two-dose Moderna COVID-19 vaccine regimen, and will be assigned to receive a booster dose of a vaccine about 12 to 20 weeks later, according to the NIH.

      Trial investigators will evaluate participants for safety and any side effects after vaccination. Participants also will be asked to provide blood samples periodically so that trial investigators can evaluate immune responses against current circulating strains of SARS-CoV-2, as well as emerging variants, according to the NIH.

      Initial trial results are expected in late summer this year. 

      MorePhoto

      Most popular in 24h

      MoreTop news

      MoreVideo

      LINE
      Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
      Copyright ©1999-2021 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.
      主站蜘蛛池模板: 国产亚洲精品福利在线无卡一| 亚洲精品成a人在线观看| 日本亚洲视频在线| 国产黄在线观看免费观看不卡| 国产大片91精品免费观看男同 | 人妻巨大乳hd免费看| 亚洲成av人在片观看| 又粗又长又爽又长黄免费视频| 77777亚洲午夜久久多人| 国产在线观看xxxx免费| 久久精品国产亚洲夜色AV网站| 午夜不卡久久精品无码免费| 亚洲av无码一区二区三区乱子伦| 无码午夜成人1000部免费视频| 亚洲视频在线不卡| 无码国产精品一区二区免费I6 | 自怕偷自怕亚洲精品| 91大神免费观看| 亚洲中文无码卡通动漫野外| 毛片网站免费在线观看| 在线观看国产一区亚洲bd| 精品久久久久久亚洲中文字幕 | 日韩a级无码免费视频| 亚洲伦理一区二区| 无人在线观看完整免费版视频| 亚洲爆乳AAA无码专区| 国产成人精品曰本亚洲79ren| 久久青草91免费观看| 国产美女无遮挡免费视频网站| 美女视频黄a视频全免费网站一区| 久久国产成人精品国产成人亚洲| 两个人看的www免费视频中文| 亚洲欧洲日产韩国在线| 国产一级淫片视频免费看| 免费看一区二区三区四区| 亚洲毛片基地4455ww| 亚洲性日韩精品一区二区三区| 1000部禁片黄的免费看| 免费无遮挡无遮羞在线看| 免费人成激情视频| 国产免费一区二区视频|